BCHE and metabolic syndrome: Our data offer novel insights into potential mechanisms of brain dysfunction in obesity and the BChE and γGT inhibition and NO elevation might represent a novel strategy for the treatment of obesity with dyslipidemia and BOS, also demonstrate the efficacy of HCA in weight management.